Uniphar Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 2/6
Uniphar verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 17.2%, während die Gewinne der Branche Healthcare jährlich um gewachsen und zwar um 11.1%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von gewachsen von 10.3%. Die Eigenkapitalrendite von Uniphar beträgt 13% und die Nettomargen betragen 1.7%.
Wichtige Informationen
17.2%
Wachstumsrate der Gewinne
8.8%
EPS-Wachstumsrate
| Healthcare Wachstum der Industrie | 13.4% |
| Wachstumsrate der Einnahmen | 10.3% |
| Eigenkapitalrendite | 13.0% |
| Netto-Marge | 1.7% |
| Letzte Ertragsaktualisierung | 30 Jun 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
The Price Is Right For Uniphar plc (ISE:UPR)
Nov 16
Analysts Are Updating Their Uniphar plc (ISE:UPR) Estimates After Its Half-Year Results
Sep 06Here's Why Shareholders May Want To Be Cautious With Increasing Uniphar plc's (ISE:UPR) CEO Pay Packet
May 03Is There An Opportunity With Uniphar plc's (ISE:UPR) 37% Undervaluation?
Apr 20Investors Met With Slowing Returns on Capital At Uniphar (ISE:UPR)
Jan 31Uniphar plc's (ISE:UPR) 25% Jump Shows Its Popularity With Investors
Dec 18These 4 Measures Indicate That Uniphar (ISE:UPR) Is Using Debt Reasonably Well
Nov 18The Returns At Uniphar (ISE:UPR) Aren't Growing
Sep 20Uniphar (ISE:UPR) Is Experiencing Growth In Returns On Capital
May 12The Uniphar plc (ISE:UPR) Full-Year Results Are Out And Analysts Have Published New Forecasts
Mar 03Estimating The Intrinsic Value Of Uniphar plc (ISE:UPR)
Dec 16Here's Why We Think Uniphar (ISE:UPR) Might Deserve Your Attention Today
Nov 24An Intrinsic Calculation For Uniphar plc (ISE:UPR) Suggests It's 45% Undervalued
Aug 01What Does Uniphar plc's (ISE:UPR) Share Price Indicate?
Jul 20Some Investors May Be Worried About Uniphar's (ISE:UPR) Returns On Capital
May 27An Intrinsic Calculation For Uniphar plc (ISE:UPR) Suggests It's 33% Undervalued
Apr 29Uniphar (ISE:UPR) Seems To Use Debt Quite Sensibly
Apr 02Here's Why I Think Uniphar (ISE:UPR) Might Deserve Your Attention Today
Mar 18Uniphar (ISE:UPR) Might Be Having Difficulty Using Its Capital Effectively
Feb 13Is Uniphar (ISE:UPR) A Risky Investment?
Dec 23Here's Why I Think Uniphar (ISE:UPR) Is An Interesting Stock
Oct 30Uniphar's (ISE:UPR) Returns On Capital Not Reflecting Well On The Business
May 14Uniphar (ISE:UPR) Has A Pretty Healthy Balance Sheet
Mar 10Does Uniphar's (ISE:UPR) Share Price Gain of 83% Match Its Business Performance?
Feb 23Will The ROCE Trend At Uniphar (ISE:UPR) Continue?
Feb 02Is Weakness In Uniphar plc (ISE:UPR) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Jan 15Trade Alert: The CEO & Executive Director Of Uniphar plc (ISE:UPR), Gerard Rabbette, Has Just Spent €900k Buying 4.2% More Shares
Dec 24
Do Institutions Own Uniphar plc (ISE:UPR) Shares?
Dec 23Is Uniphar (ISE:UPR) Using Too Much Debt?
Dec 03Uniphar (ISE:UPR) Shareholders Have Enjoyed A 91% Share Price Gain
Nov 18Aufschlüsselung der Einnahmen und Ausgaben
Wie Uniphar Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 30 Jun 24 | 2,681 | 45 | 329 | 0 |
| 31 Mar 24 | 2,617 | 45 | 321 | 0 |
| 31 Dec 23 | 2,553 | 45 | 313 | 0 |
| 30 Sep 23 | 2,436 | 45 | 294 | 0 |
| 30 Jun 23 | 2,318 | 45 | 276 | 0 |
| 31 Mar 23 | 2,195 | 45 | 257 | 0 |
| 31 Dec 22 | 2,071 | 46 | 237 | 0 |
| 30 Sep 22 | 2,020 | 47 | 232 | 0 |
| 30 Jun 22 | 1,970 | 49 | 226 | 0 |
| 31 Mar 22 | 1,957 | 48 | 222 | 0 |
| 31 Dec 21 | 1,943 | 48 | 217 | 0 |
| 30 Sep 21 | 1,930 | 39 | 206 | 0 |
| 30 Jun 21 | 1,917 | 30 | 195 | 0 |
| 31 Mar 21 | 1,871 | 29 | 183 | 0 |
| 31 Dec 20 | 1,824 | 28 | 171 | 0 |
| 30 Sep 20 | 1,780 | 26 | 164 | 0 |
| 30 Jun 20 | 1,736 | 25 | 158 | 0 |
| 31 Mar 20 | 1,701 | 23 | 149 | 0 |
| 31 Dec 19 | 1,665 | 21 | 141 | 0 |
| 30 Sep 19 | 1,607 | 20 | 130 | 0 |
| 30 Jun 19 | 1,549 | 19 | 119 | 0 |
| 31 Mar 19 | 1,484 | 14 | 105 | 0 |
| 31 Dec 18 | 1,418 | 9 | 92 | 0 |
| 31 Dec 17 | 1,265 | -2 | 83 | 0 |
| 31 Dec 16 | 1,294 | 5 | 79 | 0 |
| 31 Dec 15 | 1,117 | 6 | 60 | 0 |
| 31 Dec 14 | 1,129 | -19 | 68 | 0 |
| 31 Dec 13 | 860 | -18 | 39 | 0 |
Qualität der Erträge: UPR hat hohe Qualitätseinkünfte.
Wachsende Gewinnspanne: UPRDie aktuellen Gewinnspannen (1.7%) sind niedriger als im letzten Jahr (1.9%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: UPRIn den letzten 5 Jahren sind die Gewinne von 17.2% jährlich gestiegen.
Beschleunigtes Wachstum: UPRDas Gewinnwachstum des Unternehmens im letzten Jahr (1.4%) liegt unter seinem 5-Jahres-Durchschnitt (17.2% pro Jahr).
Erträge im Vergleich zur Industrie: UPR Das Gewinnwachstum im vergangenen Jahr (1.4%) übertraf nicht die Entwicklung der Branche Healthcare 15.6% .
Eigenkapitalrendite
Hohe Eigenkapitalrendite: UPRDie Eigenkapitalrendite des Unternehmens (13%) wird als niedrig angesehen.